Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

NCT00390117

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +40 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

NCT03019055

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations: Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

NCT04748185

Conditions: B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +21 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

NCT05007860

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT

NCT05928156

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Completed

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

NCT01572662

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

NCT00074282

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 143 locations

View Trial Details

Completed

Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL

NCT01754857

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Completed

CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy

NCT01029366

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +45 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00006390

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States

Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States

View all 14 locations

View Trial Details